プロトンポンプ
信号経路図
研究分野
- 阻害剤の選択性比較
- 溶解度
| カタログ番号 | 製品カタログ | 溶解度(25°C) | ||
|---|---|---|---|---|
| 水 | DMSO | アルコール | ||
| S1354 | Lansoprazole | <1 mg/mL | 74 mg/mL | 14 mg/mL |
| S1389 | Omeprazole | <1 mg/mL | 69 mg/mL | 13 mg/mL |
| S1413 | Bafilomycin A1(Baf-A1) | <1 mg/mL | 0.1 mg/mL | 0.1 mg/mL |
| S1743 | NEXIUM (esomeprazole magnesium) | <1 mg/mL | 143 mg/mL | 143 mg/mL |
| S4075 | Zinc Pyrithione | <1 mg/mL | 30 mg/mL | <1 mg/mL |
| S2105 | Pantoprazole | <1 mg/mL | 76 mg/mL | 76 mg/mL |
| S2222 | PF-3716556 | <1 mg/mL | 79 mg/mL | 79 mg/mL |
| S4099 | Dexlansoprazole | <1 mg/mL | 74 mg/mL | <1 mg/mL |
| S4212 | Tenatoprazole | <1 mg/mL | 46 mg/mL | 14 mg/mL |
| S4665 | Rebeprazole sodium | 76 mg/mL | 76 mg/mL | 76 mg/mL |
| S4538 | Pantoprazole sodium | 81 mg/mL | 81 mg/mL | 81 mg/mL |
- Proton Pump阻害剤(11)
- 新Proton Pump製品
| 製品コード | 製品説明 | 文献中の使用例 | お客様のフィードバック |
|---|---|---|---|
| S1354 |
LansoprazoleLansoprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. |
||
| S1389 |
OmeprazoleOmeprazoleは一種のプロトンポンプ阻害剤ですが、消化不良、消化性潰瘍、胃食道逆流症、咽喉頭酸逆流とZollinger-Ellison症候群の治療に使用されます。 |
||
| S1413 |
Bafilomycin A1(Baf-A1)Bafilomycin A1(Baf-A1)は、空胞の H+-ATPase阻害剤で、 IC50 が 0.44 nMです。 |
Expressions of LC3-I and LC3-II in protein were detected by Western blotting. Bafilomycin A1 significantly inhibited the effect of PNU282987 on LC3-II/I ratio in LPS-stimulated BV2 microglia (n = 6 per group).
|
|
| S1743 |
NEXIUM (esomeprazole magnesium)Esomeprazole magnesium is a proton pump inhibitor to reduce gastric acid secretion. |
||
| S4075 |
Zinc PyrithioneZinc pyrithioneは、 プロトンポンプを妨げることによって膜輸送を崩壊させている抗真菌薬と抗菌薬です。 |
||
| S2105新 |
PantoprazolePantoprazole is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. |
||
| S2222 |
PF-3716556PF-03716556 is a potent, and selective acid pump antagonist with pIC50 of 6.026 ¡À 0.112, 6.038 ¡À 0.039 and 6.009 ¡À 0.209 at pH 6.4 for the inhibition of H+, K+-ATPase activity of porcine, canine and human ion-leaky membrane vesicles, respect |
||
| S4099 |
DexlansoprazoleDexlansoprazole、ランソプラゾールの右旋性鏡像異性体は、デュアル遅延放出特性を有するように配合プロトンポンプインヒビター（PPI）です。 |
||
| S4212 |
TenatoprazoleTenatoprazole is a prodrug of the proton pump inhibitor (PPI) class, which inhibits proton transport with IC50 of 3.2 μM. |
||
| S4665 |
Rebeprazole sodium |
||
| S4538 |
Pantoprazole sodium |
| 製品コード | 製品説明 | 文献中の使用例 | お客様のフィードバック |
|---|---|---|---|
| S1354 |
LansoprazoleLansoprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. |
||
| S1389 |
OmeprazoleOmeprazoleは一種のプロトンポンプ阻害剤ですが、消化不良、消化性潰瘍、胃食道逆流症、咽喉頭酸逆流とZollinger-Ellison症候群の治療に使用されます。 |
||
| S1413 |
Bafilomycin A1(Baf-A1)Bafilomycin A1(Baf-A1)は、空胞の H+-ATPase阻害剤で、 IC50 が 0.44 nMです。 |
Expressions of LC3-I and LC3-II in protein were detected by Western blotting. Bafilomycin A1 significantly inhibited the effect of PNU282987 on LC3-II/I ratio in LPS-stimulated BV2 microglia (n = 6 per group).
|
|
| S1743 |
NEXIUM (esomeprazole magnesium)Esomeprazole magnesium is a proton pump inhibitor to reduce gastric acid secretion. |
||
| S4075 |
Zinc PyrithioneZinc pyrithioneは、 プロトンポンプを妨げることによって膜輸送を崩壊させている抗真菌薬と抗菌薬です。 |
||
| S2105新 |
PantoprazolePantoprazole is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. |
||
| S2222 |
PF-3716556PF-03716556 is a potent, and selective acid pump antagonist with pIC50 of 6.026 ¡À 0.112, 6.038 ¡À 0.039 and 6.009 ¡À 0.209 at pH 6.4 for the inhibition of H+, K+-ATPase activity of porcine, canine and human ion-leaky membrane vesicles, respect |
||
| S4099 |
DexlansoprazoleDexlansoprazole、ランソプラゾールの右旋性鏡像異性体は、デュアル遅延放出特性を有するように配合プロトンポンプインヒビター（PPI）です。 |
||
| S4212 |
TenatoprazoleTenatoprazole is a prodrug of the proton pump inhibitor (PPI) class, which inhibits proton transport with IC50 of 3.2 μM. |
||
| S4665 |
Rebeprazole sodium |
||
| S4538 |
Pantoprazole sodium |
